Feit Electric Acquires Universal Security Instruments' Assets and Brand
Strategic acquisition expands Feit Electric into the home safety category with the trusted USI brand and patented alarm technologies
United Security Instruments Line of Home Safety Products
LOS ANGELES, May 23, 2025 (GLOBE NEWSWIRE) -- Feit Electric, a leading global manufacturer of lighting and smart home solutions, today announced it has acquired substantially all the assets of Universal Security Instruments Inc. (NYSE American: UUU), including its trusted brand and portfolio of patented home safety technologies.
Founded in 1969, Universal Security Instruments (USI) has been a pioneer in smoke, fire, and carbon monoxide alarm innovation for more than five decades. With 11 U.S. patents and a strong retail presence across North America, USI is a name consumers trust to protect what matters most.
'This acquisition marks an exciting new chapter for Feit Electric as we expand into the home safety category,' said Alan Feit, president of Feit Electric. 'By adding USI's proven technology and respected brand to our portfolio, we can offer retailers and consumers a more complete suite of solutions for the modern home. We're committed to carrying forward USI's legacy of innovation, while enhancing its reach with Feit Electric's resources and retail partnerships.'
Under Feit Electric's ownership, the USI brand will continue to operate as a standalone line, with a focused mission on delivering reliable, easy-to-use safety and security products. The brand will retain its core identity while gaining access to Feit Electric's global scale, enhanced product development capabilities, and industry-leading execution.
'The addition of Universal Security Instruments strengthens our expanding brand portfolio, which now includes Feit Electric, LIFX, and USI, each tailored to meet different customer needs with complementary value propositions,' said Sunil Ramchandani, chief strategy officer at Feit Electric. 'This multi-brand strategy enables us to deepen retail partnerships, expand consumer choice, and lead across key smart home and safety categories.'
Feit Electric will work closely with retail partners to support the USI brand with updated assortments, refreshed packaging, enhanced marketing, and expanded online visibility. The result will be a stronger, more innovative offering in both traditional and smart safety categories built for today's connected home.
About Feit ElectricFeit Electric is a leading global manufacturer of energy-efficient lighting and smart home products, committed to innovation, quality, and customer satisfaction. Founded in 1978 and headquartered in California, Feit Electric delivers cutting-edge solutions that make homes safer, smarter, and more sustainable. The company's trusted brands—Feit Electric, LIFX, and USI serve millions of customers through leading retailers and distribution partners worldwide.
For more information, visit feit.com, lifx.com, or universalsecurity.com.
Media Contact: press@feit.com
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/9d3ccfc2-774f-48ef-bb86-eddfe0cc011d
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Indianapolis Star
5 hours ago
- Indianapolis Star
Tecogen to Participate in Roth Conference in London
NORTH BILLERICA, MA / ACCESS Newswire Tecogen Inc. (NYSE American:TGEN) a leading manufacturer of clean energy products, today announced that Abinand Rangesh, Chief Executive Officer, will participate in the 15 th Annual Roth Conference hosted in London, England on June 24 th to 26 th, 2025. Management will be available for one-on-one meetings during the conference. Attending investors interested in meeting Dr. Rangesh should contact their Roth representative or email investorrelations@ About Tecogen Tecogen designs, manufactures, sells, installs, and maintains high efficiency, ultra-clean, cogeneration products including engine-driven combined heat and power, air conditioning systems, and high-efficiency water heaters for residential, commercial, recreational and industrial use. The company provides cost effective, environmentally friendly and reliable products for energy production that nearly eliminate criteria pollutants and significantly reduce a customer's carbon footprint. In business for over 35 years, Tecogen has shipped more than 3,200 units, supported by an established network of engineering, sales, and service personnel in key markets in North America. For more information, please visit or contact us for a free Site Assessment. Forward Looking Statements This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995 and other federal securities laws that involve a number of risks and uncertainties. Forward-looking statements generally can be identified by the use of forward-looking terminology such as 'believe,' 'expect,' 'anticipate,' 'intend,' 'plan,' 'estimate,' 'project,' 'target,' 'potential,' 'will,' 'should,' 'seek,' 'could,' 'likely,' 'may,' 'pro forma,' 'anticipate,' 'continue,' or other variations thereof (including their use in the negative), or by discussions of strategies, plans or intentions. All statements, other than statements of historical fact included in this press release regarding our strategy, future operations, future financial position, future revenues, projected costs, prospects and plans and objectives of management are forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors that may cause our actual results to differ materially from those expressed or implied by such forward-looking statements. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Forward-looking statements speak only as of the date on which they are made, and we undertake no obligation to update or revise any forward-looking statements. In addition to those factors described in our Annual Report on Form 10-K, our Quarterly Reports on Form 10-Q and in our Form 8-K, under 'Risk Factors,' among the factors that could cause actual results to differ materially from past and projected future results are the following: fluctuations in demand for our products and services, competing technological developments, issues relating to research and development, the availability of incentives, rebates, and tax benefits relating to our products and services, changes in the regulatory environment relating to our products and services, integration of acquired business operations, and the ability to obtain financing on favorable terms to fund existing operations and anticipated growth. Tecogen Media & Investor Relations Contact Information: Abinand Rangesh, CEO P: 781-466-6487 E: SOURCE: Tecogen, Inc.
Yahoo
5 hours ago
- Yahoo
Rafael Holdings Reports Third Quarter Fiscal 2025 Financial Results
Cyclo Therapeutics' TransportNPC™ Phase 3 clinical trial for Trappsol® Cyclo™ for the treatment of Niemann-Pick Disease Type C1, a rare and fatal genetic disease, is fully enrolled and results from the 48-week interim analysis are expected later this month NEWARK, N.J., June 11, 2025 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc. (NYSE: RFL; NYSE American: RFL-WT), today reported its financial results for the third quarter and first nine months of fiscal year 2025 ended April 30, 2025. 'We are pleased to have completed our merger with Cyclo Therapeutics and look forward to reporting the topline data from the 48-week interim analysis of the pivotal Phase 3 TransportNPC™ study evaluating Trappsol® Cyclo™ for the treatment of Niemann-Pick Disease Type C1 anticipated later this month,' said Howard Jonas, Chief Executive Officer, Executive Chairman and Chairman of the Board of Rafael Holdings. Mr. Jonas added, 'We have enhanced our financial position with the closing of a $25 million rights offering earlier this month which will support advancing this potential new treatment option for patients suffering from this rare genetic disease.' Rafael Holdings, Inc. Third Quarter Fiscal Year 2025 Financial Results As of April 30, 2025, we had cash and cash equivalents of $37.9 million. On June 4, 2025, the Company announced the closing of a $25 million rights offering, which, including the funding of the backstop commitment by the Jonas family, raised net proceeds of $24.9 million after deduction of certain expenses incurred in connection with the offering. For the three months ended April 30, 2025, we recorded a net loss attributable to Rafael Holdings of $4.8 million, or $0.19 per share, versus a net loss of $32.4 million, or $1.36 per share in the year ago period. The year over year decrease in net loss is attributable to non-cash items, primarily unrealized losses of $1.4 million on the Company's investment in Cyclo equity which we purchased in advance of the potential merger in the current period versus $4.4 million in the year ago period, combined with an in-process R&D expense of $89.9 million related to the acquisition of Cornerstone, partially offset by a $31.3 million recovery of receivables from Cornerstone in the year ago period. Research and development expenses were $3.0 million for the three months ended April 30, 2025, compared to $1.5 million in the year ago period. The year over year increase relates to the inclusion in the current year period of spending at Cyclo Therapeutics following the March 25, 2025 merger and the activity of Cornerstone and Day Three which were consolidated with Rafael Holdings during fiscal 2024. General and administrative expenses were $3.2 million for the three months ended April 30, 2025, compared to $1.9 million in the year ago period. The year over year increase relates to the inclusion of Cyclo Therapeutics following closing of the merger, and the activity of Cornerstone and Day Three, following their consolidation. Rafael Holdings, Inc. First Nine Months Fiscal Year 2025 Financial Results For the nine months ended April 30, 2025, we recorded a net loss attributable to Rafael Holdings of $18.4 million, or $0.73 per share, versus a net loss of $29.9 million, or $1.26 per share in the year ago period. The year over year decrease in net loss is attributable to in-process R&D expense of $89.9 million related to the acquisition of Cornerstone net with a $31.3 million recovery of receivables from Cornerstone in the year ago period and $3.2 million in unrealized gains on the Company's investment in Cyclo equity. Research and development expenses were $5.3 million for the nine months ended April 30, 2025, compared to $2.6 million in the year ago period. The year over year increase relates to the merger with Cyclo Therapeutics which closed on March 25, 2025, and the activity of Cornerstone and Day Three, which were consolidated with Rafael Holdings during fiscal 2024. For the nine months ended April 30, 2025, general and administrative expenses were $8.3 million compared to $6.5 million in the same period in the prior year. The year over year increase relates to the merger with Cyclo Therapeutics which closed on March 25, 2025, and the activity of Cornerstone and Day Three, which were consolidated with Rafael Holdings during fiscal 2024. About Rafael Holdings, Inc. Rafael Holdings, Inc. holds interests in clinical and early-stage pharmaceutical and certain other companies, including our wholly owned subsidiary, Cyclo Therapeutics, LLC, a clinical stage biotechnology company dedicated to developing Rafael's lead clinical candidate, Trappsol® Cyclo™, which is being evaluated in clinical trials for the potential treatment of Niemann-Pick Disease Type C1 ('NPC1'), a rare, fatal, and progressive genetic disorder. Rafael also holds majority equity interests in LipoMedix Pharmaceuticals Ltd., a clinical stage pharmaceutical company, Cornerstone Pharmaceuticals, Inc., formerly known as Rafael Pharmaceuticals Inc., a cancer metabolism-based therapeutics company, Rafael Medical Devices, LLC, an orthopedic-focused medical device company developing instruments to advance minimally invasive surgeries, and Day Three Labs, Inc., a company which empowers third-party manufacturers to reimagine their existing cannabis offerings. Forward Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation statements regarding our expectations surrounding the potential, safety, efficacy, and regulatory and clinical progress of our product candidates; plans regarding the further evaluation of clinical data; and the potential of our pipeline, including our internal cancer metabolism research programs. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, those disclosed under the caption 'Risk Factors' in our Annual Report on Form 10-K for the year ended July 31, 2024, and our other filings with the SEC. These factors could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent management's estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change. Contact:Barbara 274-2825 RAFAEL HOLDINGS, INC. CONSOLIDATED BALANCE SHEETS (in thousands, except share and per share data) April 30, 2025 July 31, 2024 (audited) ASSETS CURRENT ASSETS Cash and cash equivalents $ 37,936 $ 2,675 Available-for-sale securities — 63,265 Interest receivable — 515 Prepaid clinical trial costs 2,968 — Convertible note receivables, due from Cyclo — 5,191 Accounts receivable, net of allowance for credit losses of $245 at April 30, 2025 and July 31, 2024 414 426 Inventory 288 — Prepaid expenses and other current assets 837 430 Total current assets 42,443 72,502 Property and equipment, net 1,614 2,120 Non-current prepaid clinical trial costs 1,399 — Investments – Cyclo — 12,010 Investments - Hedge Funds — 2,547 Convertible note receivable classified as available-for-sale 1,719 1,146 Goodwill 28,278 3,050 Intangible assets, net 1,027 1,847 In-process research and development 31,575 1,575 Other assets 41 35 TOTAL ASSETS $ 108,096 $ 96,832 LIABILITIES AND EQUITY CURRENT LIABILITIES Accounts payable $ 7,793 $ 2,556 Accrued expenses 1,866 1,798 Convertible notes payable 614 614 Other current liabilities 93 113 Due to related parties 664 733 Installment note payable — 1,700 Total current liabilities 11,030 7,514 Accrued expenses, noncurrent 3,445 2,982 Convertible notes payable, noncurrent 76 73 Other liabilities 25 5 Deferred income tax liability 9,002 — TOTAL LIABILITIES 23,578 10,574 COMMITMENTS AND CONTINGENCIES EQUITY Class A common stock, $0.01 par value; 35,000,000 shares authorized, 787,163 shares issued and outstanding as of April 30, 2025 and July 31, 2024 8 8 Class B common stock, $0.01 par value; 200,000,000 shares authorized, 31,240,188 issued and outstanding (excluding treasury shares of 101,487) as of April 30, 2025, and 24,142,535 issued and 23,819,948 outstanding (excluding treasury shares of 101,487) as of July 31, 2024 312 238 Additional paid-in capital 296,648 280,048 Accumulated deficit (220,169 ) (201,743 ) Treasury stock, at cost; 101,487 Class B shares as of October 31, 2024 and July 31, 2024 (168 ) (168 ) Accumulated other comprehensive income related to unrealized income on available-for-sale securities 219 111 Accumulated other comprehensive income related to foreign currency translation adjustment 3,728 3,691 Total equity attributable to Rafael Holdings, Inc. 80,578 82,185 Noncontrolling interests 3,940 4,073 TOTAL EQUITY 84,518 86,258 TOTAL LIABILITIES AND EQUITY $ 108,096 $ 96,832 RAFAEL HOLDINGS, INC. CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (unaudited, in thousands, except share and per share data) Three Months Ended April 30, Nine Months Ended April 30, 2025 2024 2025 2024 Revenues $ 362 $ 336 $ 567 $ 472 Cost of Infusion Technology revenue 31 85 106 85 Cost of product revenue 9 — 9 — SG&A Expenses 3,170 1,923 8,284 6,524 R&D Expenses 3,003 1,526 5,276 2,627 In-process R&D expense — 89,861 — 89,861 Depreciation and amortization 62 102 238 157 Loss on impairment of goodwill — — 3,050 — Operating Loss (5,913 ) (93,161 ) (16,396 ) (98,782 ) Interest income 472 502 1,529 1,777 Loss on initial investment in Day Three upon acquisition — — — (1,633 ) Realized gain on available-for-sale securities — 945 178 1,521 Realized loss on investment in equity securities — — — (46 ) Realized gain on investment - Cyclo — — — 424 Unrealized (loss) gain on investments - Cyclo (1,393 ) (4,395 ) (5,144 ) 3,199 Unrealized gain (loss) on convertible notes receivable, due from Cyclo 383 — (719 ) — Unrealized loss on investments - Hedge Funds — (3 ) — (118 ) Recovery of receivables from Cornerstone — 31,305 — 31,305 Interest expense (165 ) (85 ) (490 ) (85 ) Other income, net 154 — 74 118 Loss before Incomes Taxes (6,462 ) (64,892 ) (20,968 ) (62,320 ) Benefit from income taxes 2,411 2,599 2,379 2,593 Equity in loss of Day Three — — — (422 ) Consolidated net loss (4,051 ) (62,293 ) (18,589 ) (60,149 ) Net income (loss) attributable to noncontrolling interests 728 (29,942 ) (163 ) (30,207 ) Net loss attributable to Rafael Holdings, Inc. $ (4,779 ) $ (32,351 ) $ (18,426 ) $ (29,942 ) Loss per share Basic and diluted (0.19 ) (1.36 ) (0.73 ) (1.26 ) Loss per basic common share $ (0.19 ) $ (1.36 ) $ (0.73 ) $ (1.26 ) Weighted average shares in calculation 25,238,501 23,777,493 23,131,655 23,687,781 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
8 hours ago
- Yahoo
Equinox Gold Provides Updated 2025 Gold Production and Cost Guidance, 2025 Full-year Pro Forma Guidance, Including Calibre Mining Assets, of 785,000 - 915,000 Ounces of Gold, Greenstone Mine Expecting Strong H2 2025
Vancouver, British Columbia--(Newsfile Corp. - June 11, 2025) - Equinox Gold Corp. (TSX: EQX) (NYSE American: EQX) ("Equinox Gold" or the "Company") is updating its 2025 production and cost guidance to reflect the business combination with Calibre Mining Corp. ("Calibre"), which is expected to close around the end of June 2025, and the slower-than-planned ramp-up at the Company's Greenstone Gold Mine ("Greenstone") in Ontario, Canada. The Company expects pro forma full-year 2025 production of 785,000 to 915,000 ounces of gold, with total cash costs ("TCC") of $1,400 to $1,500 per ounce and all-in sustaining costs ("AISC") of $1,800 to $1,900 per ounce, including Calibre's full-year guidance (see Calibre news release dated January 8, 2025). Pro forma guidance excludes production and costs from Calibre's Valentine Gold Mine ("Valentine") and Equinox Gold's Los Filos Complex. Equinox Gold will host a conference call and webcast to discuss pro forma guidance on Thursday, June 12, 2025 commencing at 7:00 am PT (10:00 am ET). Login and dial-in details are included at the end of this news release. Greg Smith, President & CEO of Equinox Gold, stated: "Since achieving commercial production at Greenstone in Q4 2024, the ramp-up has been slower than planned. Mine productivity and equipment availability, particularly with the primary loading fleet, have fallen short of plan, impacting mining rates and delaying access to higher-grade ore zones. Further, year-to-date mined grades have been below expectations, in part due to higher-than-anticipated dilution. On the processing side, while we are seeing improvements in throughput and recovery, year-to-date performance is also below plan. We are addressing the shortfalls and are revising Greenstone full-year production guidance to 220,000 to 260,000 ounces of gold. Reflecting this change, some refinements to our other assets and the anticipated completion of the business combination with Calibre, consolidated pro forma 2025 guidance is 785,000 to 915,000 ounces of gold at an AISC of $1,800 to $1,900 per ounce, excluding Valentine and Los Filos. For Q2 2025, we expect consolidated production of 135,000 to 145,000 ounces of gold from Equinox Gold mines, including 45,000 to 50,000 ounces from Greenstone. Calibre's Q2 2025 production is estimated at 70,000 to 72,500 ounces of gold. Full-year Calibre and pro forma consolidated guidance is included below to provide visibility into the scale of the combined company." Darren Hall, President & CEO of Calibre Mining, stated: "As incoming President and Chief Operating Officer of Equinox Gold, I have been working closely on integration and to address the operational opportunities identified through due diligence and subsequent reviews. I believe a reset of expectations is necessary to establish a foundation for long-term shareholder value creation. While Greenstone is one part of the broader portfolio, it is a key asset and an immediate focus. The Company has mobilized additional human capital to support the site, and an improvement and optimization plan is underway. In May, mining rates averaged 175,000 tonnes per day, representing a 25% increase over Q1 2025 performance. With early gains visible in mining performance, I anticipate continued quarter-over-quarter improvement at Greenstone, with stronger production expected in the second half of the year. Construction and commissioning at Valentine in Newfoundland are progressing well and the mine remains on schedule, with first gold anticipated by the end of Q3 2025. I am encouraged with progress at Valentine, with the primary crusher recently commissioned and delivering material to the coarse ore stockpile (watch the video here). Given the commissioning experience of our operating team, I anticipate an effective and efficient ramp-up to name plate capacity." Table 1: Pro Forma Consolidated Full-year 2025 Equinox Gold Guidance (including Calibre assets from Jan 1, 2025)Gold Production/Sales (ounces) TCC($/ounce)1 AISC($/ounce)1 Growth Capital($ million)1 Exploration($ million) Greenstone 220,000 - 260,000 $1,275 - $1,375 $1,700 - $1,800 $80 - $85 $2 - $3 Brazil 250,000 - 270,000 $1,725 - $1,825 $2,275 - $2,375 $35 - $40 $21 - $24 Mesquite 85,000 - 95,000 $1,200 - $1,300 $1,800 - $1,900 $10 - $15 $2 - $3 Nicaragua 200,000 - 250,000 $1,200 - $1,300 $1,400 - $1,500 $60 - $70 $25 - $30 Pan 30,000 - 40,000 $1,600 - $1,700 $1,600 - $1,700 $5 - $10 $5 - $10 Newfoundland N/A N/A N/A N/A $15 - $20 Total 785,000 - 915,000 $1,400 - $1,500 $1,800 - $1,900 $190 - $220 $70 - $90 Table 2: Equinox Gold 2025 Revised GuidanceGold Production/Sales (ounces) TCC($/ounce)1 AISC($/ounce)1 Growth Capital ($ million)1 Exploration($ million) Greenstone 220,000 - 260,000 $1,275 - $1,375 $1,700 - $1,800 $80 - $85 $2 - $3 Brazil 250,000 - 270,000 $1,725 - $1,825 $2,275 - $2,375 $35 - $40 $21 - $24 Mesquite 85,000 - 95,000 $1,200 - $1,300 $1,800 - $1,900 $10 - $15 $2 - $3 Consolidated 555,000 - 625,000 $1,460 - $1,560 $1,970 - $2,070 $125 - $140 $25 - $30 Table 3: Equinox Gold 2025 Original GuidanceGold Production/Sales (ounces) TCC($/ounce)1 AISC($/ounce)1 Growth Capital ($ million)1 Exploration($ million) Greenstone 300,000 - 350,000 $790 - $890 $1,045 - $1,145 $35 N/A Brazil 245,000 - 295,000 $1,365 - $1,465 $1,855 - $1,955 $51 N/A Mesquite 90,000 - 105,000 $1,235 - $1,335 $1,725 - $1,825 $16 N/A Consolidated 635,000 - 750,000 $1,075 - $1,175 $1,455 - $1,550 $102 N/A Table 4: Calibre Mining 2025 GuidanceGold Production/Sales (ounces) TCC($/ounce)1 AISC ($/ounce)1 Growth Capital ($ million)1 Exploration ($ million) Nicaragua 200,000 - 250,000 $1,200 - $1,300 $1,400 - $1,500 $60 - $70 $25 - $30 Nevada 30,000 - 40,000 $1,600 - $1,700 $1,600 - $1,700 $5 - $10 $5 - $10 Newfoundland N/A N/A N/A N/A $15 - $20 Consolidated 230,000 - 280,000 $1,300 - $1,400 $1,500 - $1,600 $70 - $80 $50 - $60 Calibre guidance does not include Valentine, which is expected to pour first gold by the end of Q3 2025. Conference Call and Webcast Equinox Gold will host a conference call and webcast to discuss pro forma guidance on Thursday, June 12, 2025 commencing at 7:00 am PT (10:00 am ET). The webcast will be archived on Equinox Gold's website until December 12, 2025. Conference callToll-free in U.S. and Canada: 1-833-752-3366 International callers: +1 647-846-2813 Webcast login About Equinox Gold Equinox Gold is a growth-focused Canadian mining company operating entirely in the Americas. The Company has operating gold mines in Canada, the USA and Brazil and has a path to achieve more than one million ounces of annual gold production by advancing a pipeline of expansion projects. Equinox Gold's common shares are listed on the TSX and the NYSE American under the trading symbol EQX. Further information about Equinox Gold's portfolio of assets and long-term growth strategy is available at or by email at ir@ Equinox Gold Contacts Greg Smith, President & CEORhylin Bailie, Vice President Investor RelationsTel: +1 604-558-0560Email: ir@ ________________ 1. Total cash costs, all-in sustaining costs and growth capital (non-sustaining capital) are non-IFRS measures. See Non-IFRS Measures and Cautionary Notes. Qualified Person The scientific and technical information contained in this news release related to Equinox Gold assets was approved by Doug Reddy, MSc, Equinox Gold's Chief Operating Officer and a "Qualified Person" under National Instrument 43-101. The scientific and technical information contained in this news release related to Calibre assets was approved by David Schonfeldt, Calibre's Corporate Chief Geologist and a "Qualified Person" under National Instrument 43-101. Non-IFRS Measures This news release refers to total cash costs (TCC) and all-in sustaining costs (AISC) per ounce sold, which are measures with no standardized meaning under International Financial Reporting Standards (IFRS) and may not be comparable to similar measures presented by other companies. Their measurement and presentation are intended to provide additional information and should not be considered in isolation or as a substitute for measures of performance prepared in accordance with IFRS. Non-IFRS measures are widely used in the mining industry as measurements of performance and the Company believes that they provide further transparency into costs associated with producing gold and will assist analysts, investors and other stakeholders of the Company in assessing its operating performance, its ability to generate free cash flow from current operations and its overall value. Refer to the "Non-IFRS measures" section of Equinox Gold's MD&A for the year ended December 31, 2024, and the "Non-IFRS measures" section of Calibre's MD&A for the year ended December 31, 2024, for a more detailed discussion of these non-IFRS measures and their calculation. Cautionary Notes and Forward-looking Statements This news release contains certain forward-looking information and forward-looking statements within the meaning of applicable securities legislation and may include future-oriented financial information or financial outlook information (collectively "Forward-looking Information"). Actual results of operations and the ensuing financial results may vary materially from the amounts set out in any Forward-looking Information. Forward-looking Information in this news release relates to, among other things: expected pro-forma 2025 production and cost guidance; the expected benefits of the business combination with Calibre (the "Transaction") and the attributes of Equinox Gold post-Transaction; the anticipated receipt of all required approvals for the Transaction and timing for consummation of the Transaction; the strategic vision for Equinox Gold, and expectations regarding exploration potential, production capabilities, future financial or operating performance, investment returns and share price performance; expectations for the operation of Greenstone, including future financial or operating performance and anticipated improvements in recovery rates, mining rates and throughput to achieve design capacity; expectations for completing construction and commissioning at Valentine; and expectations for future success of the combined management team. Forward-looking Information is generally identified by the use of words like "believe", "will", "achieve", "strategy", "plan", "vision", "improve", "intend", "anticipate", "expect", "estimate", and similar expressions and phrases or statements that certain actions, events or results "may", "could", or "should", or the negative connotation of such terms, are intended to identify Forward-looking Information. Although the Company believes that the expectations reflected in such Forward-looking Information are reasonable, but undue reliance should not be placed on Forward-looking Information since the Company can give no assurance that such expectations will prove to be correct. Forward-looking information is based on Equinox Gold and Calibre's current expectations for future events and these assumptions include: the ability to successfully combine the assets and teams of Equinox Gold and Calibre; the ability to meet exploration, production, cost and development goals, including expected completion of Valentine construction and commissioning and the successful ramp-up to design capacity at both Greenstone and Valentine; gold prices remaining as estimated; no unplanned delays or interruptions; ore grades and recoveries remain consistent with expectations; expectations regarding the financial impact of tariffs; expectations for the impact of macroeconomic factors on the Company's operations, share price performance and gold price; currency exchange rates remaining as estimated; availability of funds for projects and future cash requirements; prices for energy inputs, labour, materials, supplies and services remaining as estimated; the accuracy of Mineral Reserve and Mineral Resource estimates and the assumptions on which they are based; and the ability of Equinox Gold to work productively with its Indigenous partners at Greenstone. Forward-looking Information is based on information available at the time those statements are made and/or good faith belief of the officers and directors of Equinox Gold as of that time with respect to future events and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in or suggested by the Forward-looking Information. Forward-looking Information involves numerous risks, uncertainties and other factors that may cause actual results and developments to differ materially from those expressed or implied by such Forward-looking Information. Such factors include, without limitation, risks relating to: changes in the gold price; Canadian and United States sanctions on Nicaraguan operations; the financial impact that tariffs placed on Canada or Mexico by the United States and risks related to retaliatory tariffs placed on the United States by either Canada or Mexico; new members of management and the board of Equinox Gold; fluctuations in prices for energy inputs, labour, materials, supplies and services; fluctuations in currency markets; operational risks and hazards inherent with the business of mining (including environmental accidents and hazards, geotechnical failures, industrial accidents, equipment breakdown, unusual or unexpected geological or structural formations, cave-ins, flooding, fire and severe weather); inadequate insurance, or inability to obtain insurance to cover these risks and hazards; relationships with, and claims by, local communities and Indigenous populations; Equinox Gold's ability to obtain all necessary permits, licenses and regulatory approvals in a timely manner or at all; changes in laws, regulations and government practices, including mining laws, and the factors identified in the section titled "Risks Related to the Business" in Equinox Gold's most recently filed Annual Information Form which is available on SEDAR+ at and on EDGAR at and in the section titled "Risk Factors" in Calibre's most recently filed Annual Information Form which is available on SEDAR+ at Forward-looking Information is designed to help readers understand Equinox Gold's views as of that time with respect to future events and speak only as of the date they are made. Except as required by applicable law, Equinox Gold assumes no obligation to update or to publicly announce the results of any change to any Forward-looking Information to reflect actual results, future events or developments, changes in assumptions or changes in other factors affecting the Forward-looking Information. If Equinox Gold updates any Forward-looking Information, no inference should be drawn that the Company will make additional updates with respect to that or other Forward-looking Information. All Forward-Looking Information contained in this news release is expressly qualified in its entirety by this cautionary statement. To view the source version of this press release, please visit Sign in to access your portfolio
